https://www.selleckchem.com/pr....oducts/elacestrant.h
Moxidectin is an antiparasitic drug belonging to the class of the macrocyclic lactones, subgroup mylbemicins. It is used worldwide in veterinary practice, but little is known about its potential environmental risks. Thus, we used the zebrafish embryo as a model system to study the potential effects of moxidectin on aquatic non-target organisms. The analyses were performed in two experimental sets (1) acute toxicity and apical endpoints were characterized, with biomarker assays providing information on the activity levels of catalase